| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biomarin Pharmaceutical Inc. (BMRN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. BMRN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 159.4K | $9.01M | - | |
| VP | 80.0K | $4.52M | - | |
| VP | 55.1K | $3.11M | - | |
| Dir | 49.4K | $2.79M | - | |
| Dir | 46.4K | $2.62M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2016 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 53,125 | $93.65 | $4,974,901.25 | -12.3% | |
| Sep 27, 2016 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sell | 18,467 | $95.61 | $1,765,648.34 | -30.9% | |
| Sep 16, 2016 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 137,368 | $95.34 | $13,096,960.72 | -10.8% | |
| Aug 26, 2016 | Fuchs Henry J | EVP, Chief Medical Officer | Sale+OE | 15,000 | $95.06 | $1,425,924.00 | -11.6% | |
| Aug 16, 2016 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 41,666 | $91.49 | $3,811,868.18 | -9.9% | |
| Aug 1, 2016 | Spiegelman Daniel K59 | EVP, Chief Financial Officer | Sell | 4,000 | $99.33 | $397,320.00 | -8.5% | |
| Aug 1, 2016 | Davis George Eric64 | EVP, General Counsel | Sell | 2,167 | $100.00 | $216,700.00 | -3.0% | |
| Aug 1, 2016 | Mueller Brian64 | VP, Corporate Controller | Sell | 287 | $100.00 | $28,700.00 | -2.0% | |
| Jul 27, 2016 | Lawlis V Bryan53 | Director | Sale+OE | 1,100 | $95.39 | $104,926.80 | -7.4% | |
| Jul 22, 2016 | Lawlis V Bryan53 | Director | Sale+OE | 6,400 | $95.01 | $608,064.00 | -31.6% |